Corvus Pharmaceuticals Announces Positive Data from Cohort 4 Confirming Results for Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis

Cohort 4 data demonstrated positive safety and efficacy results, including additional clinical benefit observed following ...
Seeking Alpha

TransCode Therapeutics Announces Initial Dosing in Fourth Cohort of Phase 1 Clinical Trial with TTX-MC138

First patient in Cohort four has been treated with TTX-MC138 Ten patients have been treated with TTX-MC138 at escalating dose levels Additional patients being evaluated for eligibility for expanded ...
SpaceNews

APPLICATIONS OPEN FOR COHORT 4 OF SDA TAP LAB – CATALYST CAMPUS MINI ACCELERATOR

Catalyst Campus is proud to announce they are now accepting applications for Cohort 4 of the SDA TAP Lab – Catalyst Campus Mini Accelerator, a high-impact accelerator program designed to connect ...
Morningstar

TransCode Therapeutics Announces Initial Dosing in Fourth Cohort of Phase 1 Clinical Trial with TTX-MC138

Cohort 4 builds upon our safety, PK/PD and exploratory data and is an important element of our clinical development strategy. We believe this milestone will inform the dose expansion stage of the ...